麻豆传媒

Dr. Tardif is Associate Director of Research and Senior Management Team member for SNPRC and has extensive experience coordinating large, integrated research projects throughout her professional career. She served as the marmoset expert for the team charged with sequencing the marmoset genome and as the species expert for recent studies on development of induced pluripotent stem cell (iPS cell) technologies. Her research is focused on metabolism, behavior and reproduction and, most recently, on the characterization of the marmoset as a model for obesity and aging. Dr. Tardif has more than 30 years of expertise in the development of common marmoset monkeys as biomedical models in diverse areas including: Reproductive biology Infectious disease Neuroscience Aging and obesity

Dr. Patterson’s laboratory works on the development of countermeasures against potential biological weapons. Her group focuses on the development of therapies and vaccines against naturally occurring pathogens that can cause sporadic but lethal outbreaks, and her most recent studies concentrate on hemorrhagic fever viruses. Dr. Patterson has been involved in the development of three vaccines against Ebola and two vaccines against Lassa fever that are undergoing further studies. Her lab utilizes the maximum containment laboratory (BSL-4) at Texas Biomed. Dr. Patterson helped develop a marmoset model used for multiple infectious agents: Ebola virus Marburg virus Lassa fever Eastern Equine Encephalitis virus